Ethics and Policy · Reproductive Ethics
Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Grebe TA, Khushf G, Greally JM, Turley P, Foyouzi N, Rabin-Havt S, Berkman BE, Pope K, Vatta M, Kaur S, ACMG Social, Ethical, Legal Issues Committee
Cite this paper
Grebe, T. A., Khushf, G., Greally, J. M., Turley, P., Foyouzi, N., Rabin-Havt, S., Berkman, B. E., Pope, K., Vatta, M., Kaur, S., ACMG Social, Ethical, & and Legal Issues Committee (2024). Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. https://doi.org/10.1016/j.gim.2023.101052
Grebe TA, Khushf G, Greally JM, Turley P, Foyouzi N, Rabin-Havt S, Berkman BE, Pope K, Vatta M, Kaur S, ACMG Social, Ethical; and Legal Issues Committee. Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2024. doi:10.1016/j.gim.2023.101052
Grebe, T. A., et al. "Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)." Genet Med, 2024.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Free to read at the publisher (reported by Unpaywall and OpenAlex, not verified by RRM Academy)
